Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans

American Journal of Nephrology

Volumn 16, Issue 2, 1996, Pages 128-137

  Vesely, David L ^a   Preston, Richard ^b   Gower, William R ^a   Chiou, Shirley ^a   Epstein, Murray ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial natriuretic peptide; Central hypervolemia; Kaliuretic peptide; Water immersion

Indexed keywords

ATRIAL NATRIURETIC FACTOR; POTASSIUM; WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIURESIS; HOMEOSTASIS; HUMAN; HYPERVOLEMIA; KALIURESIS; LIVER CIRRHOSIS; PRIORITY JOURNAL; WATER IMMERSION;

EID: 0030031580     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168984     Document Type: Article

References (33)

1. Epstein M: Renal sodium handling in cirrhosis. Semin Nephrol 1983;3:225-240.
2. Epstein M: Renal sodium handling in cirrhosis: in Epstein M (ed): The Kidney in Liver Disease. ed 3. Baltimore. Williams & Wilkins. 1988. pp 3-30.
3. Epstein M: The sodium retention of cirrhosis: A reappraisal. Hepatology 1986:6:312-315.
4. Warner L, Skorecki K, Blcndis LM, Epstein M: Atrial natriuretic factor and liver disease. Hepatology 1993:17:500-513.
5. Epstein M: Hepatorenal syndrome: Emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol 1994:4:1735-1753.
6. Dehold AJ. Borenstein HB. Veress AT. Sonnen-berg H: A rapid and potent natriuretic response to the intravenous injection of atrial myocardial extract in rats. Life Sei 1981:28:89-94.
7. Currie MG, Geller DM, Cole BR, Boylen JG, Yu Sheng W, Holmberg SW, Needleman P: Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria. Science 1983; 221:71-73.
8. Epstein M: Atrial natriuretic factor in patients with liver disease. Am J Nephrol 1989:9:89-100.
9. Epstein M, Loutzenhiser R, Norsk P, Atlas S: Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humans. Am J Nephrol 1989;9:133-143.
10. Vesely DL: Atrial Natriuretic Hormones. Englewood Cliffs. Prentice Hall, 1992, pp 1-256.
11. Martin DM, Peavahouse JB, Trigg DJ, Vesely DL, Buerkert JE: Three peptides from the ANF prohormone NHi-terminus are natriuretic and/or kaliuretic. Am J Physiol 1990:258: F1401–F1408.
12. Vesely DL, Douglass MA, Dietz JR. Giordano AT. McCormick MT. Rodriguez-Paz G, Schocken DD: Prohormone atrial natriuretic peptide 79-98 (kaliuretic stimulator) lowers blood pressure and increases potassium excretion. Circulation 1993:88:1331.
13. Vesely DL, Douglass MA. Dietz JR, Gower WR Jr. McCormick MT. Rodriguez-Paz G. Schocken DD; Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 1994;90:1129-1140.
14. Vesely DL, Douglass MA, Dietz JR, Giordano AT, McCormick MT, Rodriguez-Paz G, Schocken DD: Negative feedback of atrial natriuretic peptides. J Clin Endocrinol Metab 1994:78:1128-1134.
15. Gower WR Jr, Chiou S. Skolnick K, Vesely DL: Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 1994:15:861-867.
16. Epstein M, Pins DS, Sancho J, Haber E: Suppression of plasma renin and plasma aldosterone during water immersion in normal man. J Clin Endocrinol Mctab 1975:41:618-625.
17. Levinson R. Epstein M. Sackner MA. Begin R: Comparison of the effects of water immersion and saline infusion on central hemodynamics in man. Clin Sei Mol Med 1977;52:343-350.
18. Epstein M: Renal effects of head-out water immersion in man: Implications for an understanding of volume homeostasis. Physiol Rev 1978;58:529-581.
19. Epstein M: Renal effects of head-out water immersion in humans: A 15-year update. Physiol Rev 1992:72:563-619.
20. Epstein M, Re R, Preston S, Haber E: Comparison of the suppressive effects of water immersion and saline administration on rcnin-aldo-stcrone in normal man. J Clin Endocrinol Me-tab 1979;49:358-363.
21. Anderson JV. Millar ND. O’Hare JP. Mackenzie JC, Corrall RJM, Bloom SR: Atrial natriuretic peptide: Physiological release associated with natriuresis during water immersion in man. Clin Sei 1986:71:319-322.
22. Epstein M. Loutzenhiser RD. Friedland E, Aceto RM, Camargo MJF. Atlas SA: Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans. J Clin Invest 1987;79:738-745.
23. Pendergasl DR. DeBold AJ. Pazik M. Ilong SK: Effect of head-out immersion on plasma atrial natriuretic factor in man. Proc Soc Exp Biol Med 1987;184:429-435.
24. Vesely DL, Norsk P. Winters CJ, Rico DM, Sallman AL, Epstein M: Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans. Proc Soc Exp Biol Med 1989: 192:230-235.
25. Vescly DL. Preston R, Winters CJ, Rico DM, Sallman AL. Epstein M: Increased release of the N-terminal and C-terminal portions of the atrial natriuretic factor prohormone during immersion-induced central hypervolemia in cirrhotic humans. Am J Nephrol 1991:11:207-216.
26. Vesely DL, Gower WR Jr, Giordano AT, Frietll FE: Atrial natriuretic peptides in the heart and hemolymph of the oyster, Crassos-irca virginica: A comparison with vertebrates. Comp Biochem Physiol [B] 1993; 106:535- 546.
27. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rice DM, Vesely DL: The N-terminus and a 4000 molecular weight peptide from the midportion of the atrial natriuretic factor prohormone each circulate in man and increase in congestive heart failure. Circulation 1989:80: 438-449.
28. Henriksen JH. Schütten HJ. Bendtsen F. War-berg J: Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosis. Liver 1986:6:361-368.
29. Ackerman BH, Wyeth RP, Vesely DL. Ngo WL. Bissett JK. Winters CJ. Sallman AL: Pharmacokinetic characterization of the post-distri-bution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs. J Clin Pharmacol 1992;32:415-421.
30. Ngo L, Wyeth RP. Bissett JK. Hester WL, Newton MT. Sallman AL. Winters CJ, Vesely DL: Prohormone atrial natriuretic peptides I-30. 31-67 and 99-126 increase in proportion to right ventricular pacing rate. Am Heart J 1989:117:385-390.
31. Winters CJ, Sallman AL, Meadows J. Rico DM. Vesely DL: Two new hormones: Prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man. Biochem Biophys Res Commun 1988:150:231-236.
32. Winters CJ. Vescly DL: Change in plasma im-munoreactive N-terminus, C-terminus, and 4000 dalton midportion of atrial natriuretic factor prohormone with hemodialysis. Nephron 1991;58:17-22.
33. Vesely DL. Winters CJ: Atrial natriuretic factor in the ascitic fluid of cirrhotic patients. J Med 1989;20:208-216.